Long‐Term Outcome of Chronic Hepatitis B—Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma
Journal of Viral Hepatitis · 2025-03 · 32 (3)
DOI: 10.1111/jvh.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 29.01.2025. Verfasst von Anders Eilard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Carcinoma, Hepatocellular, Hepatitis B virus, Liver Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement, Cancerfonden.
Abstract (Originalsprache)
Current guidelines to prevent hepatocellular carcinoma (HCC) by chronic hepatitis B virus (HBV) infection are based on risk assessments that include age, sex, and virological and biochemical parameters. The study aim was to investigate the impact of predictive markers on long‐term outcomes. The clinical outcomes of 100 patients with chronic hepatitis B were investigated 30 years after a baseline assessment that included liver biopsy. A favourable outcome—HBsAg loss or HBeAg‐negative infection (ENI; previously termed ‘inactive carrier’)—was observed in 74% of all patients, whereas 7% developed HCC. HBsAg loss was observed in 75% of patients with genotype A, compared with 42%, 33% and 0% with genotypes D, B and C, respectively ( p < 0.0001). HCC developed in 3 patients (33%) with genotype C as compared with 3 (17%), 1 (2%) and 0 patients with genotypes B, D and A, respectively ( p < 0.0001). In multiple logistic regression analysis, both HBsAg loss and HCC were associated with HBV genotype and baseline HBV DNA level, and HCC also with histological score. The results suggest that genotyping and histological assessment may improve outcome prediction and help decisions about HCC screening, particularly in populations with HBV‐infected individuals of mixed geographic origin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg, Sweden.
ORCID-Profile: Johan Ringlander, Magnus Lindh
Förderung
- Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement
- Cancerfonden
Zitieren
APA
Eilard, A., Ringlander, J., Andersson, M. E., Nilsson, S., Norkrans, G., & Lindh, M. (2025). Long‐Term Outcome of Chronic Hepatitis B—Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma. Journal of Viral Hepatitis, 32(3). https://doi.org/10.1111/jvh.70008
Vancouver
Eilard A, Ringlander J, Andersson ME, Nilsson S, Norkrans G, Lindh M. Long‐Term Outcome of Chronic Hepatitis B—Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma. Journal of Viral Hepatitis. 2025;32(3). doi:10.1111/jvh.70008
BibTeX
@article{Eilard2025,
author = {Eilard, Anders and Ringlander, Johan and Andersson, Maria E and Nilsson, Staffan and Norkrans, Gunnar and Lindh, Magnus},
title = {Long‐Term Outcome of Chronic Hepatitis B—Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma},
journal = {Journal of Viral Hepatitis},
year = {2025},
volume = {32},
number = {3},
doi = {10.1111/jvh.70008}
}
EUVIMED